Parameterkatalog
| Kurzbezeichnung | Anti-Laminin 332 |
|---|---|
| Referenzbereich | Titer ab 1:10 positiv
|
| Methode | Indirekte Immunfluoreszenz-Färbung |
| Messungenauigkeit | Semiquantitative Methode |
| Literatur | - Harrist TJ, Mihm MC Jr: Cutaneous Immunopathology. The diagnostic use of direct and indirect immunofluorescence techniques in dermatologic diseases. Human Pathol 10:625, 1979 - Witte M, Zillikens D, Schmidt E. Diagnosis of Autoimmune Blistering Diseases. Front Med (Lausanne). 2018 Nov 2;5:296. - Amber KT, Bloom R, Hertl M. A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):72-7. - Schmidt E et al. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol. 2021 Oct;35(10):1926-1948. doi: 10.1111/jdv.17395. |
| Indikation | Diagnose und Therapiemonitoring bei Autoimmunbullösen Dermatosen |
| Probenmaterial | Serum |
| Analysendauer/Frequenz | 2h/2/Woche |
| PageID | 439 |
| Letzte Änderung am | 27.08.2024 |
| Verrechnungsinfo | 72,02 Euro laut ASK 5110 [2026] |